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Background: The identification of filamentous fungi and/or yeasts in the airway secretions of individuals with cystic fibrosis (CF) is becoming
increasingly prevalent; yet the importance of these organisms in relation to underlying inflammation is poorly defined.
Methods: Cystic fibrosis bronchial epithelial cells (CFBE) and human bronchial epithelial cells (HBE) were co-incubated with Candida albicans
whole cells or Aspergillus fumigatus conidia for 24 h prior to the measurement of pro-inflammatory cytokines IL-6 and IL-8 by ELISA.
Results: Treatment of HBE or CFBE with C. albicans whole cells did not alter cytokine secretion. However treatment of CFBE with A. fumigatus
conidia resulted in a 1.45-fold increase in IL-6 and a 1.65-fold increase in IL-8 secretion in comparison to basal levels; in contrast there was far
less secretion from HBE cells.
Conclusion: Our data indicate that A. fumigatus infection modulates a pro-inflammatory response in CF epithelial cells while C. albicans does not.
Crown Copyright © 2011 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. All rights reserved.Keywords: Fungi; Epithelial cells; Inflammation1. Introduction
Individuals with CF are susceptible to infection with a range of
opportunistic pathogens identified in sputum culture in a time-
ordered pattern [1]. Bacteria including Pseudomonas aeruginosa,
Staphylococcus aureus, Burkholderia cepacia complex and
Stenotrophomonas maltophilia are typically associated with
recurrent exacerbations in pulmonary disease underlying the
irreversible airway damage and ultimate morbidity and mortality
in CF [1]. In addition to these bacterial pathogens the sputum
culture frequently isolates yeasts and/or filamentous fungi.
Aspergillus fumigatus, a saprophytic fungal pathogen found⁎ Corresponding author at: Room 03/24, Health Sciences Building, School of
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1569-1993/$ - see front matter. Crown Copyright © 2011 Published by Elsevier B
doi:10.1016/j.jcf.2011.06.006worldwide has a very high sporulating capacity resulting in the
ubiquitous presence of airborne conidia small enough in diameter
(2–3 μM) to penetrate deeply into the airway [2]. Elimination of
conidia by the innate immune response means healthy humans
rarely have any adverse effects. However in immunocompro-
mised patients A. fumigatus is of growing significance in relation
to allergic bronchopulmonary aspergillosis (ABPA), chronic
colonisation/infection (bronchitis) and post-transplant fungaemia.
In terms of colonisation of the CF airways A. fumigatus is the
most common filamentous fungal agent identified [3] and is
positively associated with hospital admissions [4]. The frequency
of A. fumigatus recovery from individuals with CF has been
reported anywhere between 25 and 60% [5–8].Candida albicans,
ubiquitous commensal dimorphic yeast, is the most common
fungal pathogen of humans and accounts for more than 50% of all
fungal systemic infections [9] and is frequently isolated from the
sputum of CF patients [10]..V. on behalf of European Cystic Fibrosis Society. All rights reserved.
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demonstrated A. fumigatus or C. albicans infection can elicit a
pro-inflammatory response; implicated in the development of
protective immunity against systemic infections [11–14]. How-
ever, despite the increasing prevalence of fungal identification in
the respiratory secretions from CF patients the effect of fungal
infection on the pro-inflammatory response in a CF setting is
poorly defined. The aim of the present studywas to investigate the
hypothesis that CF epithelial cells will have an exaggerated pro-
inflammatory response to stimulation with yeast (C. albicans) or
filamentous fungi (A. fumigatus) commonly isolated from the
airways of patients with CF.
2. Methods
2.1. Fungal isolates
The present study utilised wildtype isolates of C. albicans and
A. fumigatus from adult CF patients and archived at the CF fungal
repository at the Northern Ireland Public Health Laboratory. The
C. albicans and A. fumigatus isolates were from a female F508del/
F508del and a male F508del/F508del patient respectively. The
identification of each isolate was confirmed through sequencing of
the internal transcribed spacer (ITS) 1 region of the rRNA gene
operon [15].
2.2. Generation of fungal preparations
C. albicanswas cultured in Nagano's media (without selective
substances) [16] for 6 h at 37 °C (corresponding to the early
exponential phase of growth) prior to irradiation with 25 kGy
60Co to ensure microbiological sterility. Whole yeast cells were
isolated by centrifugation at 2000×g for 10 min at 4 °C, washed
and resuspended in sterile PBS prior to enumeration with a
haemocytometer. A. fumigatus was grown on Sabouraud's
dextrose agar supplemented with chloramphenicol (Oxoid
CM0041, Oxoid Ltd., Basingstoke) for 5 days at 37 °C. Conidia
were then harvested from the plate by gentle scraping into a
PBS/0.025% v/v Tween solution. The solution was filtered
through a BD Falcon cell strainer (40 μM pore) to ensure a pure
conidial preparation without hyphal contamination. Conidia
were irradiated, washed and enumerated as described for the
C. albicans preparation.
2.3. Epithelial cell culture
A human bronchial epithelial cell line (16HBE41o-) and a
delta F508 homozygote bronchial epithelial cell line (CFBE410-)
were maintained in a humidified atmosphere of 95% air and 5%
CO2 at 37 °C. All flasks and plates used for growing cells were
pre-coated with a solution comprising LHC media (Invitrogen)
(98%), fetal bovine serum (PAA laboratories) (1%) and PureCol
collagen type I (Nutacon) (1%). Cells were maintained in Eagle's
minimum essential medium (PAA laboratories) supplemented
with 10% heat inactivated fetal bovine serum (PAA laboratories),
2 mM glutamine (PAA laboratories), 100 U/ml penicillin and
100 μg/ml streptomycin (Invitrogen).2.4. THP1 cell culture
THP-1 cells (human acute monocytic leukaemia cell line)
were maintained in RPMI 1640 medium (PAA laboratories)
supplemented with 10% heat inactivated FBS (PAA laborato-
ries), 100 U/ml penicillin and 100 μg/ml streptomycin (Invitro-
gen) in a humidified atmosphere of 95% air and 5% CO2 at
37 °C.
2.5. Simulation experiments
HBE and CFBE (8×104 cells in 0.5 ml) and THP-1 cells
(2.5×105 cells in 0.25 ml) were seeded in 24-well plates prior
to incubation in the presence or absence of various doses of
fungal preparations. A. fumigatus conidia or C. albicans whole
cells were added to epithelial or THP-1 cells at various ratios
based on the cell seeding density. Cell culture supernatants were
collected after 24 h then centrifuged at 1500×g for 10 min to
remove any cell debris. Samples were stored at −70 °C until
assayed.
2.6. ELISA
IL-6 and IL-8 levels were determined by ELISA kits supplied
by R&D systems. Assays were performed in accordance with the
manufacturer's instructions. For all ELISA assays a number of
additional controls were included throughout the study. PBS
(vehicle control) added to epithelial or THP-1 cells did not alter
IL-6 or IL-8 secretion compared with basal (data not shown). Cell
culture media, A. fumigatus conidia or C. albicans whole cells
alone did not cause the release of any measurable level of IL-6 or
IL-8 (b10 pg/ml) (data not shown). A positive control (denoted as
cytomix) comprising 10 ng/ml IL-1β, 10 ng/ml TNFα and
1000 U/ml IFN-γ was also utilised throughout the study (data
not shown).
2.7. Cytotoxicity assays
To ensure that all treatments utilised throughout this study were
performed at non-toxic doses cytotoxicity was assessed by release
of lactate dehydrogenase (LDH) employing the LDH-Cytotoxicity
Assay Kit II (Bio Vision, California, USA) performed as described
by the manufacturer.
2.8. Statistical analysis
All values are expressed as the mean±SE. Statistical analysis
was performed using ANOVA. pb0.05 was considered
significant. Data analysis was carried out using Excel.
3. Results
3.1. Effect of C. albicans treatment on cytokine release from
HBE and CFBE
IL-6 or IL-8 levels were unaffected in HBE or CFBE after
challenge with C. albicans whole cells over a range of doses
403J.A. Reihill et al. / Journal of Cystic Fibrosis 10 (2011) 401–406(Fig. 1A and B). Similar results were found when experiments
were performed using the alternative sequenced C. albicans
isolates SC5314 [17] and WO-1 [18] (data not shown). It has
previously been shown that exposure of THP-1 cells to live
C. albicans results in an increase in IL-8 secretion from these
cells [19]. We therefore employed the THP-1 cell line as a
positive control for our C. albicans preparations. In contrast
to epithelial cell lines THP-1 cells exposed to C. albicans did
result in an increase in IL-8 secretion compared with basal
levels (pb0.05) (Fig. 1C).
3.2. Effect of A. fumigatus treatment on cytokine release from
HBE and CFBE
A. fumigatus conidia modulated IL-6 and IL-8 secretion in a
dose-dependent fashion when added to CFBE (Fig. 2A and B).
Exposure of CFBE to the lower range of doses caused a dose-
dependent increase in cytokine secretion that was maximal at 50:1
conidia to epithelial cell ratio (IL-6 2441±305 pg/ml, pb0.05
and IL-8 1482±117 pg/ml, pb0.01) in comparison to basal levels
(IL-6 1684±169 pg/ml and IL-8 907±64 pg/ml) (Fig. 2A and B).
In contrast treatment of CFBE with higher doses of A. fumigatus
(250:1 conidia to epithelial cell ratio) reduced cytokine release to
below basal levels (IL-6: 1040±157 pg/ml, pb0.05) (IL-8: 726±
74, p=0.088) (Fig. 2A and B). A. fumigatus conidia did not have
any effect on cytokine release from HBE at the lower range of
doses (1:1–50:1 conidia to epithelial cell ratio), however high dose0
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Fig. 1. Cytokine release from Candida albicans-treated HBE and CFBE. HBE (filled d
albicans whole cells as indicated for 24 h then IL-6 (A) and IL-8 (B) levels determin
following values HBE IL-6 1695±305 pg/ml, IL-8 2013±117 pg/ml CFBE: IL-6 30
treated with an equal ratio (1:1) of Candida albicans whole cells (n=3) or Aspergillu
of THP-1 cells with cytomix gave the following: 1083±114.9 pg/ml. *pb0.05 comtreatment (250:1 conidia: epithelial cell ratio) did tend to reduce
cytokine levels (IL-6: 751±108 pg/ml pb0.05, IL-8: 588±94 pg/
ml p=0.063) in comparison to basal secretion (IL-6: 1013±
97 pg/ml, IL-8: 878±102 pg/ml). The reduction in cytokine
secretion seen at high-dose A. challenge is not attributable to a
cytotoxic effect as LDH levels remained unaltered under these
conditions (Fig. 2C). In experiments where THP1 cells were
challenged with A. fumigatus conidia IL-8 secretion was
unaffected (Fig. 1C).
4. Discussion
The central finding of our study is that A. fumigatus conidia
stimulate a pro-inflammatory response in CF bronchial epithelial
cells. Treatment of these cells with low doses of conidia increases
cytokine secretion in a dose-dependent fashion (1–50:1 conidia to
epithelial cell ratio); an effect that was not apparent in HBE cells
(Fig. 2A and B). This finding is in agreement with the hypothesis
that CFBE may be more pro-inflammatory in nature compared
with non-CF epithelial cells upon fungal challenge.
In contrast incubation of HBE and CFBE with higher doses
of A. fumigatus (N100:1 conidia to epithelial cell ratio) resulted
in a significant reduction in IL-6 levels and a tendency where
IL-8 levels were also diminished compared with spontaneous
secretion (Fig. 2A and B). Although there is a paucity of data in
this area there are a number of potential mechanisms whereby
fungal pathogens can reduce cytokine secretion.0
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Fig. 2. Cytokine release from Aspergillus fumigatus-treated HBE and CFBE. HBE (filled diamonds) and CFBE (filled squares) were treated with varying doses of
Aspergillus fumigatus conidia as indicated for 24 h then IL-6 (A) and IL-8 (B) levels determined by ELISA. Data shown in A and B is representative of at least 6
independent experiments. Treatment of cells with cytomix resulted in the following cytokine levels HBE IL-6 1795±236 pg/ml, IL-8 2022±116 pg/ml CFBE: IL-6
2983±335 pg/ml, IL-8 2320±310 pg/ml. (C) HBE or CFBE were treated with varying doses of Aspergillus fumigatus conidia then LDH levels were measured (n=3).
A 1% v/v LDH solution in culture media served as a positive control. *pb0.05 **pb0.01 compared with basal.
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ways represent one mechanism whereby fungi can potentially
dampen inflammation. Proteases from fungal extracts are known
as potent inducers of epithelial cell desquamation and production
of pro-inflammatory cytokines [20]. A report by Kauffman and
colleagues has demonstrated that A. fumigatus protease extracts
added to epithelial cells elicit a bell-shaped dose response for IL-6
and IL-8 release [21]. Cytokine production increased in a dose-
dependent fashion (maximal at 10 μg/ml) which rapidly declined
to below basal levels at higher concentrations (over 10 μg/ml)
when added to A549 cells; with similar results found in primary
nasal cells [21]. While these data are strikingly similar to our
findings (Fig. 2A and B) the fact that our conidial preparations are
inactivated by γ-irradiation diminishes the likelihood that PPAR
signalling is responsible for our effects (though it is possible that
some residual protease activity remains after γ-irradiation). It
may be possible that the reduction in cytokine levels seen in
our studies is mediated through changes in Toll-like receptor
(TLR) expression. The expression of TLRs, which are pattern
recognition receptors that recognise conserved molecular pat-
terns, is important in the innate response against microbes in
the epithelium. TLRs are known to be involved in the recognition
of fungal pathogens including A. fumigatus and C. albicans
generally leading to the production of cytokines, activation ofleukocytes and subsequent resistance to infection. Fungi can
however modulate TLR signalling pathways to induce an anti-
inflammatory response. For example TLR4 signalling, regarded
as important for the recognition of A. fumigatus conidia, is lost
during germination of A. fumigatus conidia to hyphae [22];
whereasC. albicans infection has been demonstrated to promote a
TLR2-mediated anti-inflammatory phenotype [23]. Although as
in our studies the samples were irradiated thus not able to
germinate, this exact mechanism cannot explain our findings.
It is tempting to speculate that in CF epithelial cells low
doses of A. fumigatus conidia cause a normal inflammatory
response; but above a certain threshold can modulate epithelial
cell signalling pathways to dampen the pro-inflammatory
response. This may represent a mechanism for A. fumigatus to
escape host detection enabling airway colonisation.
Historically C. albicans has been regarded as a commensal
organism of relatively low pathogenic potential compared with
other bacterial pathogens and A. spp. [10]. Consistent with this
notion, in our investigation C. albicans treatment did not alter
cytokine release from HBE or CFBE suggesting that C. albicans
has little pro-inflammatory effect on bronchial epithelial cells.
However, a very recent paper has reported that C. albicans
colonisation significantly predicts hospital-treated exacerbations
and accelerates rates of decline for BMI and FEV1 [24]. The
405J.A. Reihill et al. / Journal of Cystic Fibrosis 10 (2011) 401–406underlyingmechanisms for these effects remain unknown though
they were best-predicted by pancreatic insufficiency, osteopenia
and co-colonisation with Pseudomonas spp. [24].
Our findings that C. albicans stimulates IL-8 release
from THP-1 cells and A. fumigatus conidia modulate IL-6 and
IL-8 release from bronchial epithelial cells demonstrate that
irradiation did not have a chronic effect on our preparations.
The use of non-irradiated preparations may be of additional
value as viability is a known virulence factor for C. albicans
(and A. fumigatus) [13,14]. Thus it is feasible that live fungal
preparations may evoke a more prominent response in bronchial
epithelial cells.
Although initially not included in the scope of the present study
some experiments were performed using THP-1 cell lines as a
positive control forC. albicans-mediated IL-8 secretion. The effect
of C. albicans challenge on IL-8 release from THP-1 cells
highlights that fungi potentially exert effects on non-epithelial cells
relevant to CF. Although A. fumigatus did not alter IL-8 levels in
THP1 cells it has been shown to stimulate leukocyte adhesion
molecules in endothelial cells during invasive pulmonary disease
[25]. Additionally it should be noted that in our experiments only a
1:1 fungi (yeast cell or conidia) to THP-1 cell ratio was
investigated; in contrast to the epithelial cell studies where a
range of concentrations was studied. A more focused approach is
required to better understand the role of fungal infection, in
particular with relation toA. fumigatus, in this setting. Suchwork is
of importance as yeast or filamentous fungi may modulate
leukocytes (neutrophils) contributing to the amplified pro-
inflammatory phenotype associated with CF.
Fungal pathogens in the CF lung must also be considered
in the back-drop of polymicrobial infection. Bidirectional
signalling between clinical isolates of C. albicans and Pseudo-
monas aeruginosa has previously been shown [26]. In addition to
specific signalling between pathogens their presence in the same
environment may be of significance. The formation of hyphae by
C. albicans orA. fumigatus is important for the adherence of fungi
to epithelium. Hyphae can penetrate epithelial tissue and as such
may potentially provide unwanted access to other deleterious
pathogens/molecules.
Overall we have demonstrated that A. fumigatus stimulates a
pro-inflammatory response to a greater degree in CF bronchial
epithelial cells compared with non-CF bronchial epithelial cells.
C. albicans did not affect the pro-inflammatory response in
our system. Additional investigation of the molecular mecha-
nisms by which filamentous fungi and yeast modulate CF
bronchial epithelial cells, and also their interaction with other cell
types and pathogens present in the CF lung may provide novel
insights into the merits and potential therapeutic targets for anti-
fungal intervention.Acknowledgements
This work was financially supported by the Cystic Fibrosis
Trust (PJ546). We gratefully acknowledge Professor J.R Rao
for his expert assistance in regard to the irradiation of fungal
preparations.References
[1] O'SullivanBP, FreedmanSD.Cystic fibrosis. LancetMay 30 2009;373(9678):
1891–904.
[2] Latge JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol
Aug. 2001;9(8):382–9.
[3] Pihet M, Carrere J, Cimon B, Chabasse D, Delhaes L, Symoens F, et al.
Occurrence and relevance of filamentous fungi in respiratory secretions of
patients with cystic fibrosis—a review.MedMycol Jun. 2009;47(4):387–97.
[4] Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection
with Aspergillus fumigatus on lung function and hospitalization in patients
with cystic fibrosis. Chest Jan. 2010;137(1):171–6.
[5] Sudfeld CR, Dasenbrook EC, Merz WG, Carroll KC, Boyle MP.
Prevalence and risk factors for recovery of filamentous fungi in individuals
with cystic fibrosis. J Cyst Fibros Mar. 2010;9(2):110–6.
[6] Nelson LA, CallerameML, Schwartz RH. Aspergillosis and atopy in cystic
fibrosis. Am Rev Respir Dis Oct. 1979;120(4):863–73.
[7] Bakare N, Rickerts V, Bargon J, Just-Nubling G. Prevalence of Aspergillus
fumigatus and other fungal species in the sputum of adult patients with
cystic fibrosis. Mycoses Feb. 2003;46(1–2):19–23.
[8] Valenza G, Tappe D, Turnwald D, Frosch M, Konig C, Hebestreit H, et al.
Prevalence and antimicrobial susceptibility of microorganisms isolated
from sputa of patients with cystic fibrosis. J Cyst Fibros Mar. 2008;7(2):
123–7.
[9] Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O,
et al. Epidemiology of candidaemia in Europe: results of 28-month European
Confederation of Medical Mycology (ECMM) hospital-based surveillance
study. Eur J Clin Microbiol Infect Dis Apr. 2004;23(4):317–22.
[10] Chotirmall SH, Greene CM, McElvaney NG. Candida species in cystic
fibrosis: a road less travelled. Med Mycol Nov. 2010;48(Suppl 1):S114–24.
[11] Schaller M, Mailhammer R, Grassl G, Sander CA, Hube B, Korting HC.
Infection of human oral epithelia with Candida species induces cytokine
expression correlated to the degree of virulence. J Invest Dermatol Apr.
2002;118(4):652–7.
[12] Dongari-Bagtzoglou A, Fidel Jr PL. The host cytokine responses and
protective immunity in oropharyngeal candidiasis. J Dent Res Nov. 2005;84
(11):966–77.
[13] Dongari-Bagtzoglou A, Kashleva H. Candida albicans triggers interleukin-
8 secretion by oral epithelial cells. Microb Pathog Apr. 2003;34(4):169–77.
[14] Balloy V, Sallenave JM, Wu Y, Touqui L, Latge JP, Si-Tahar M, et al.
Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithe-
lial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and
ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway. J Biol
Chem Nov. 7 2008;283(45):30513–21.
[15] Nagano Y, Elborn JS, Millar BC, Walker JM, Goldsmith CE, Rendall J,
et al. Comparison of techniques to examine the diversity of fungi in adult
patients with cystic fibrosis. Med Mycol Feb. 2010;48(1):166–76.
[16] Nagano Y,Millar BC, Goldsmith CE,Walker JM, Elborn JS, Rendall J, et al.
Development of selective media for the isolation of yeasts and filamentous
fungi from the sputumof adult patientswith cystic fibrosis (CF). J Cyst Fibros
Nov. 2008;7(6):566–72.
[17] Jones T, Federspiel NA, Chibana H, Dungan J, Kalman S, Magee BB, et al.
The diploid genome sequence of Candida albicans. Proc Natl Acad Sci
USA May 11 2004;101(19):7329–34.
[18] Butler G, Rasmussen MD, Lin MF, Santos MA, Sakthikumar S, Munro
CA, et al. Evolution of pathogenicity and sexual reproduction in eight
Candida genomes. Nature Jun. 4 2009;459(7247):657–62.
[19] Barker KS, Liu T, Rogers PD. Coculture of THP-1 human mononuclear
cells with Candida albicans results in pronounced changes in host gene
expression. J Infect Dis Sep. 1 2005;192(5):901–12.
[20] Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK. Proteases from
Aspergillus fumigatus induce release of proinflammatory cytokines and
cell detachment in airway epithelial cell lines. J Infect Dis Jul. 1997;176(1):
300–3.
[21] Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P.
Protease-dependent activation of epithelial cells by fungal allergens leads
to morphologic changes and cytokine production. J Allergy Clin Immunol
Jun. 2000;105(6 Pt 1):1185–93.
406 J.A. Reihill et al. / Journal of Cystic Fibrosis 10 (2011) 401–406[22] Netea MG, Warris A, Van der Meer JW, Fenton MJ, Verver-Janssen TJ,
Jacobs LE, et al. Aspergillus fumigatus evades immune recognition during
germination through loss of toll-like receptor-4-mediated signal transduc-
tion. J Infect Dis Jul. 15 2003;188(2):320–6.
[23] Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer
JW, van Krieken JH, et al. Toll-like receptor 2 suppresses immunity
against Candida albicans through induction of IL-10 and regulatory
T cells. J Immunol Mar. 15 2004;172(6):3712–8.
[24] Chotirmall SH, O'Donoghue E, Bennett K, Gunaratnam C, O'Neill SJ,
McElvaney NG. Sputum Candida albicans presages FEV decline andhospital-treated exacerbations in cystic fibrosis. Chest Nov. 2010;138(5):
1186–95.
[25] Chiang LY, Sheppard DC, Gravelat FN, Patterson TF, Filler SG.
Aspergillus fumigatus stimulates leukocyte adhesion molecules and
cytokine production by endothelial cells in vitro and during invasive
pulmonary disease. Infect Immun Aug. 2008;76(8):3429–38.
[26] McAlester G, O'Gara F,Morrissey JP. Signal-mediated interactions between
Pseudomonas aeruginosa and Candida albicans. J Med Microbiol May
2008;57(Pt 5):563–9.
